Effects of nemorosone, isolated from the plant Clusia rosea, on the cell cycle and gene expression in MCF-7 BUS breast cancer cell lines

Phytomedicine

Volumn 22, Issue 1, 2015, Pages 153-157

  Camargo, M S ^a   Oliveira, M T ^b   Santoni, M M ^a   Resende, F A ^a   Oliveira Hohne A P ^a   Espanha, L G ^a   Nogueira, C H ^a   Cuesta Rubio, O ^c   Vilegas, W ^a   Varanda, E A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c INSTITUTO DE FARMACIA Y ALIMENTOS   (Cuba)

Author keywords

Breast cancer; Cell cycle; Clusia rosea; Gene expression; Nemorosone

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; CYTOKERATIN 19; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN 1; MYC PROTEIN; NEMOROSONE; NOTCH1 RECEPTOR; PLANT MEDICINAL PRODUCT; PROGESTERONE RECEPTOR; PROTEIN MLH1; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN 3; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; BENZOPHENONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL POPULATION; CLUSIA; CLUSIA ROSEA; CONTROLLED STUDY; DNA REPAIR; DRUG MECHANISM; FLOW CYTOMETRY; FLOWER; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; PROTEIN DEPLETION; UNFOLDED PROTEIN RESPONSE; BREAST TUMOR; CHEMISTRY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; MCF 7 CELL LINE; PATHOLOGY;

CLUSIA ROSEA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOPHENONES; BREAST NEOPLASMS; CELL CYCLE; CLUSIA; FEMALE; FLOWERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS;

EID: 84918500254     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2014.11.007     Document Type: Article

References (26)

1. Abuhammad, S., Zihlif, M., 2012. Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics 101, 213-220.
2. Anaganti, S., Fernández-Cuesta, L., Langerød, A., Hainaut, P., Olivier, M., 2011. p53-dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines. Cancer Lett. 300, 215-224.
3. Bartek, J., Lukas, J., 2001. Mammalian G1-and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 13, 738-747.
4. Bartek, J., Lukas, J., 2003. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429.
5. Camargo, M.S., Prieto, A.M., Resende, F.A., Boldrin, P.K., Cardoso, C.R., Fernández, M.F., Molina-Molina, J.M., Olea, N., Vilegas, W., Cuesta-Rubio, O., 2013. Evaluation of estrogenic, antiestrogenic and genotoxic activity of nemorosone, the major compound found in brown Cuban propolis. BMC Complement. Altern. Med. 13, 1-8.
6. Camargo, M.S., Varela, S.D., de Oliveira, A.P.S., Resende, F.A., Cuesta-Rubio, O., Vilegas, W., Varanda, E.A., 2011. Assessment of estrogenic, mutagenic and antimutagenic activity of nemorosone. Braz. J. Pharmacog. 21, 921-927.
7. Chen, J., Sadowski, I., 2005. Identification of themismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc. Natl. Acad. Sci. U.S.A. 102, 4813-4818.
8. Ciochina, R., Grossman, R.B., 2006. Polycyclic polyprenylated acylphloroglucinols. Chem. Rev. 106, 3963-3986.
9. Cuesta-Rubio, O., Frontana-Uribe, B.A., Ramírez-Apan, T., Cárdenas, J., 2002. Polyisoprenylated benzophenones in cuban propolis; biological activity of nemorosone. Z. Naturforsch. C 57, 372-378.
10. Cuesta-Rubio, O., Velez-Castro, H., Frontana-Uribe, B.A., Cardenas, J., 2001. Nemorosone, the major constituent of floral resins of Clusia rosea. Phytochemistry 57, 279-283.
11. Diaz-Carballo, D., Gustmann, S., Acikelli, A.H., Bardenheuer, W., Buehler, H., Jastrow, H., Ergun, S., Strumberg, D., 2012. 7-Epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells. Phytomedicine 19, 1298-1306.
12. Giacinti, L., Claudio, P.P., Lopez, M., Giordano, A., 2006. Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist, 1-8.
13. Holtrup, F., Bauer, A., Fellenberg, K., Hilger, R.A., Wink, M., Hoheisel, J.D., 2011. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br. J. Pharmacol. 162, 1045-1059.
14. Jeong, K.W., Chodankar, R., Purcell, D.J., Bittencourt, D., Stallcup, M.R., 2012. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells. Mol. Endocrinol. 26, 955-966.
15. Jiao, P., Zhou, Y.S., Yang, J.X., Zhao, Y.L., Liu, Q.Q., Yuan, C., Wang, F.Z., University, T.M., 2013. MK-2206 induces cell cycle arrest and apoptosis in HepG2 cells and sensitizes TRAIL-mediated cell death. Mol. Cell. Biochem. 382, 217-224.
16. Kaplan, E., Gündüz, U., 2012. Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance. Biomed. Pharmacother. 66, 29-35.
17. 3integrin subunits. Nat. Cell Biol. 14, 567-574.
18. Lukas, J., Lukas, C., Bartek, J., 2004. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair 3, 997-1007.
19. Löfgren, L., Sahlin, L., Schoultz, B.V., Fernstad, R., Skoog, L., Schoultz, E.V., 2006. Expression of sex steroid receptor subtypes in normal andmalignant breast tissue-a pilot study in postmenopausal women. Acta Oncol. 45, 54-60.
20. Popolo, A., Piccinelli, A.L., Morello, S., Sorrentino, R., Osmany, C.R., Rastrelli, L., Pinto, A., 2011. Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells. Can. J. Physiol. Pharmacol., 50-57.
21. Simpkins, N.S., Holtrup, F., Rodeschini, V., Taylor, J.D., Wolf, R., 2012. Comparison of the cytotoxic effects of enantiopure PPAPs, including nemorosone. Bioorg. Med. Chem. Lett. 22, 6144-6147.
22. Tobin, N.P., Bergh, J., 2012. Analysis of cyclin D1 in breast cancer: a call to arms. Curr. Breast Cancer Rep. 4, 171-173.
23. Toy, W., Shen, Y., Won, H., Green, B., Sakr, R.A., Will, M., Li, Z., Gala, K., Fanning, S., King, T.A., 2013. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat. Genet. 45, 1439-1445.
24. Visser, K., Mortimer, M., Louw, A., 2013. Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo. PLoS One 8, e79223.
25. Wolf, R.J., Hilger, R.A., Hoheisel, J.D., Werner, J., Holtrup, F., 2013. In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One 8, e74555.
26. Zhang, T., Tan, Y., Zhao, R., Liu, Z., 2013. DNA damage induced by oridonin involves cell cycle arrest at G2/M phase in human MCF-7 cells. Contemp. Oncol. 17, 38-44.